ESC 365 - Co-administration of low concentrations of matrix metalloproteinase 2, myosin light chain kinase and nitric oxide synthase inhibitors protects heart from ischemia/reperfusion injury

ESC Premium Access

Co-administration of low concentrations of matrix metalloproteinase 2, myosin light chain kinase and nitric oxide synthase inhibitors protects heart from ischemia/reperfusion injury

Session: Poster session 6 - Latest on STEMI

Topic: Infarction acute phase STEMI

Speaker: Professor I. Bil-Lula (Wroclaw, PL)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Iwona Bil-Lula

Wroclaw Medical University, Wroclaw (Poland)

0 follower

70 more presentations in this session

Acquired thrombocytopenia after transcatheter aortic valve implantation (TAVI): association with clinical outcome

Speaker: Doctor C. Guerreiro (Vila Nova de Gaia, PT)

Ventricular conduction blocks: prevalence, temporal evolution, and impact on survival in cardiogenic shock

Speaker: Doctor H. Tolppanen (Helsinki, FI)

Pre-hospital and in-hospital mortality from myocardial infarction in Berlin

Speaker: Professor M. Stockburger (Nauen, DE)

Development of antithrombotic therapy and bleeding complications in patients with ACS over time: Data from a local myocardial infarction registry

Speaker: Doctor J. Roehnisch (Berlin, DE)

8-hydroxy-2-deoxyguanosine predicts microvascular obstruction after primary percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction.

Speaker: Mr Y. Minamimoto (Yokohama, JP)

Access the full session

Poster session 6 - Latest on STEMI

Speakers: Professor I. Bil-Lula, Doctor C. Guerreiro, Doctor H. Tolppanen, Professor M. Stockburger, Doctor J. Roehnisch...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources